Tuesday, October 22, 2013 12:00:46 PM
Let's compare costs. These are the prices of Big Pharma cancer pharmaceuticals that may extend the life of an advanced cancer patient from a few weeks to a few months. Average survival time is 42 days when a combination of these agents are used. Treating lung-cancer patients with so-called "breakthrough" Erbitux, a pharmaceutical that costs up to $80,000 for an 18-week regimen, was found to prolong survival by only 1.2 months on average, according to NCI. These pills do not cure the cancer, they just marginally prolong the dying time.
NCI estimated that extending the lives of the 550,000 Americans who die of cancer annually by one year would cost $440 billion,
Cost of cancer pills only. All the other elements of cancer treatment are not included. Zaltrap, $11,000/month; Yervoy, $39,000/month; Provenge, $93,000/course of treatment; Erbitux, $8,400/month; Avastin $5000/month; Gleevec, $92,000/year; Tasigna, $115,000/year; Sprycel, $123,000/year.
Dharmanol costs $25 for six tablets.
Thank you kindly.
BK
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM